3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
5
Endometrial Neoplasms
5
Neoplasms
4
Head and Neck Neoplasms
3
Breast Neoplasms
3
Rectal Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Ovarian Carcinosarcoma
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lung Neoplasms
1
Laryngeal Diseases
1
Hemangiosarcoma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Interventions
Temozolomide
3
Specimen Handling
2
tovorafenib
1
spartalizumab
1
ribociclib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
lorlatinib
1
larotrectinib
1
balstilimab
1
Vaccines
1
Receptors, Interleukin-8B
1
Radiotherapy
1
Pharmacogenomic Variants
1
Pharmacogenomic Testing
1
PTC596
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Injections
1
Immune Checkpoint Inhibitors
1
Fluid Therapy
1
Everolimus
1
Eflornithine
1
Diphtheria-Tetanus Vaccine
1
Diffusion Tensor Imaging
1
Cilengitide
1
CLR1404
1
CBLC137
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diffuse Intrinsic Pontine Glioma
×
dostarlimab
×
90 days
×
Clear all
No trials found.